F Ambrosch

1.1k total citations
51 papers, 811 citations indexed

About

F Ambrosch is a scholar working on Epidemiology, Immunology and Hepatology. According to data from OpenAlex, F Ambrosch has authored 51 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 18 papers in Immunology and 16 papers in Hepatology. Recurrent topics in F Ambrosch's work include Hepatitis B Virus Studies (16 papers), Immunodeficiency and Autoimmune Disorders (14 papers) and Hepatitis Viruses Studies and Epidemiology (13 papers). F Ambrosch is often cited by papers focused on Hepatitis B Virus Studies (16 papers), Immunodeficiency and Autoimmune Disorders (14 papers) and Hepatitis Viruses Studies and Epidemiology (13 papers). F Ambrosch collaborates with scholars based in Austria, France and Belgium. F Ambrosch's co-authors include G Wiedermann, Assad Safary, Michael Kundi, A. Delem, Francis André, David S. Fedson, H Hofmann, Herwig Kollaritsch, W Frisch-Niggemeyer and Peter G. Kremsner and has published in prestigious journals such as Vaccine, Journal of Medical Virology and PharmacoEconomics.

In The Last Decade

F Ambrosch

44 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Ambrosch Austria 16 545 415 261 154 121 51 811
A. Delem Austria 14 472 0.9× 451 1.1× 246 0.9× 68 0.4× 63 0.5× 25 650
S Thoelen Belgium 10 506 0.9× 467 1.1× 251 1.0× 185 1.2× 85 0.7× 18 816
Roland Sänger Germany 19 697 1.3× 265 0.6× 184 0.7× 144 0.9× 116 1.0× 24 881
J.P. Chiron France 13 597 1.1× 397 1.0× 185 0.7× 101 0.7× 114 0.9× 47 774
William R. Oleszko United States 8 788 1.4× 451 1.1× 251 1.0× 187 1.2× 149 1.2× 8 1.0k
K. R. Berquist United States 15 728 1.3× 504 1.2× 195 0.7× 79 0.5× 42 0.3× 28 926
R. Vranckx Belgium 18 672 1.2× 536 1.3× 180 0.7× 43 0.3× 98 0.8× 56 838
Marc Fourneau Belgium 8 606 1.1× 534 1.3× 321 1.2× 259 1.7× 36 0.3× 13 1.0k
Veronik Hutse Belgium 17 644 1.2× 214 0.5× 302 1.2× 137 0.9× 317 2.6× 43 932
Jeff Connell Ireland 20 790 1.4× 277 0.7× 434 1.7× 70 0.5× 116 1.0× 67 1.1k

Countries citing papers authored by F Ambrosch

Since Specialization
Citations

This map shows the geographic impact of F Ambrosch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Ambrosch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Ambrosch more than expected).

Fields of papers citing papers by F Ambrosch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Ambrosch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Ambrosch. The network helps show where F Ambrosch may publish in the future.

Co-authorship network of co-authors of F Ambrosch

This figure shows the co-authorship network connecting the top 25 collaborators of F Ambrosch. A scholar is included among the top collaborators of F Ambrosch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Ambrosch. F Ambrosch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ambrosch, F, et al.. (2004). Rapid Antibody Response after Vaccination with a Virosomal Hepatitis A Vaccine. Infection. 32(3). 149–152. 19 indexed citations
2.
Ambrosch, F, G Wiedermann, Michael Kundi, et al.. (2000). A hepatitis B vaccine formulated with a novel adjuvant system. Vaccine. 18(20). 2095–2101. 55 indexed citations
3.
Ambrosch, F & David S. Fedson. (1999). Influenza Vaccination in 29 Countries. PharmacoEconomics. 16(Supplement 1). 47–54. 56 indexed citations
4.
Wiedermann, G, Michael Kundi, & F Ambrosch. (1998). Estimated persistence of anti-HAV antibodies after single dose and booster hepatitis A vaccination (0-6 schedule). Acta Tropica. 69(2). 121–125. 32 indexed citations
5.
Wiedermann, G, et al.. (1997). Inactivated hepatitis A vaccine: long-term antibody persistence. Vaccine. 15(6-7). 612–615. 50 indexed citations
6.
Ambrosch, F. (1997). Immunogenicity and protectivity of a new liposomal hepatitis A vaccine. Vaccine. 15(11). 1209–1213. 102 indexed citations
7.
Ambrosch, F, et al.. (1994). Combined vaccination against yellow fever and typhoid fever: a comparative trial. Vaccine. 12(7). 625–628. 30 indexed citations
8.
9.
Wiedermann, G, et al.. (1992). Persistence of vaccine-induced antibody to hepatitis A virus. Vaccine. 10. S129–S131. 45 indexed citations
10.
Ambrosch, F, Francis André, A. Delem, et al.. (1992). Simultaneous vaccination against hepatitis A and B: results of a controlled study. Vaccine. 10. S142–S145. 37 indexed citations
11.
Wiedermann, G, F Ambrosch, Herwig Kollaritsch, et al.. (1990). Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers. Vaccine. 8(6). 581–584. 69 indexed citations
12.
Wiedermann, G, Otto Scheiner, F Ambrosch, et al.. (1988). Lack of Induction of IgE and IgG Antibodies to Yeast in Humans Immunized with Recombinant Hepatitis B Vaccines. International Archives of Allergy and Immunology. 85(1). 130–132. 15 indexed citations
13.
Ganzinger, U., et al.. (1988). Tolerability and immunogenicity of a polyvalent pseudomonas aeruginosa extract vaccine in human volunteers. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene Series A Medical Microbiology Infectious Diseases Virology Parasitology. 268(3). 376–385. 1 indexed citations
14.
Ambrosch, F, W Frisch-Niggemeyer, Peter G. Kremsner, et al.. (1987). Persistence of vaccine-induced antibodies to hepatitis B surface antigen and the need for booster vaccination in adult subjects.. PubMed. 63 Suppl 2. 129–35. 47 indexed citations
15.
Popow‐Kraupp, Therese, et al.. (1986). A controlled trial for evaluating two live attenuated mumps‐measles vaccines (Urabe Am 9‐Schwarz and Jeryl Lynn‐Moraten) in young children. Journal of Medical Virology. 18(1). 69–79. 16 indexed citations
16.
Ambrosch, F, et al.. (1984). [A new ELISA micromethod for the determination of tetanus antibodies].. PubMed. 258(2-3). 173–82. 4 indexed citations
17.
Ambrosch, F, et al.. (1979). [Influenza immunization, clinical results and serological tests (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 9(9). 399–404. 3 indexed citations
18.
Wiedermann, G & F Ambrosch. (1978). [Cost-benefit analysis in measles and mumps vaccinations].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 128(3). 73–6. 1 indexed citations
19.
Ambrosch, F, et al.. (1977). [Experimental investigations on the effect of various doses of streptokinase on blood viscosity (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 89(10). 350–3. 1 indexed citations
20.
Wiedermann, G, C Kunz, & F Ambrosch. (1976). Effect, hazards and risks of the new vaccination against tick-borne encephalitis (TBE) as calculated by special formulas.. 236. 141–144. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Delem Breakdown of academic impact, for papers by S Thoelen Breakdown of academic impact, for papers by Roland Sänger Breakdown of academic impact, for papers by J.P. Chiron Breakdown of academic impact, for papers by William R. Oleszko Breakdown of academic impact, for papers by K. R. Berquist Breakdown of academic impact, for papers by R. Vranckx Breakdown of academic impact, for papers by Marc Fourneau Breakdown of academic impact, for papers by Veronik Hutse Breakdown of academic impact, for papers by Jeff Connell
Rankless by CCL
2026